Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DARUNAVIR for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 86 adverse event reports in the FDA FAERS database where DARUNAVIR was used for Maternal exposure timing unspecified.

Most Reported Side Effects for DARUNAVIR

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 453 12.7% 81 41
Maternal exposure during pregnancy 291 8.2% 1 22
Virologic failure 266 7.5% 3 16
Drug resistance 247 6.9% 71 20
Exposure during pregnancy 210 5.9% 2 36
Death 186 5.2% 185 13
Drug interaction 183 5.1% 10 71
Treatment failure 165 4.6% 77 10
Pathogen resistance 162 4.6% 0 26
Viral mutation identified 161 4.5% 4 17
Off label use 152 4.3% 14 59
Treatment noncompliance 145 4.1% 7 29
Immune reconstitution inflammatory syndrome 143 4.0% 21 78
Premature baby 135 3.8% 13 17
Abortion spontaneous 126 3.5% 1 2

Other Indications for DARUNAVIR

Hiv infection (2,193) Product used for unknown indication (632) Antiretroviral therapy (189) Covid-19 (60) Acquired immunodeficiency syndrome (40) Covid-19 pneumonia (36) Hiv test positive (24) Coronavirus infection (22) Hiv-2 infection (20) Hepatitis c (16)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

DARUNAVIR Full Profile All Maternal exposure timing unspecified Drugs DARUNAVIR Demographics DARUNAVIR Timeline